Syphilis is reaching more women as STI trends diverge

Syphilis is rising among women in England, Australia and Europe, even as overall STI diagnoses fall in some countries. Long-term data also show increases among older adults, including older women in the US.

5 min read

Syphilis is rising among women in England, Australia and Europe, even as overall STI diagnoses fall in some countries. Long-term data also show increases among older adults, including older women in the US.

Content note: this article mentions stillbirth and infant death.

Canada's congenital syphilis rate reached 14.50 cases per 100,000 live births in 2023, against 4.50 in 2018. The figures appear in The State of Public Health in Canada 2026, published last week. That rate peaked at 32.70 in 2022, so recent data show a fall within a longer rise.

Infectious syphilis in Canada rose more than four-fold between 2014 and 2023, from 6.8 to a preliminary 30.5 per 100,000 people. Gonorrhoea reached 104.95 per 100,000 in 2023, and more cases now resist one or more treatment drugs. Chlamydia, at 323.39 per 100,000, remains the most commonly reported STI.

The Canadian report gives no STI figures by sex or for older adults. Congenital syphilis is its clearest message for women. The infection passes to a baby during pregnancy or at birth and can cause stillbirth and infant death.

Where STI numbers are rising, and where they are falling

Europe recorded record highs in 2024. The European Centre for Disease Prevention and Control (ECDC) counted 106,331 gonorrhoea cases, up 303% since 2015. It also counted 45,577 syphilis cases, more than double the 2015 level, with men who have sex with men still the most affected group.

England moved the other way in 2025. The UK Health Security Agency (UKHSA) reported 334,151 new STI diagnoses, down 8.3% on 2024.

US data for 2024 also show a fall. Chlamydia, gonorrhoea and syphilis cases dropped 9% on 2023, the third annual decline, yet the total stays 13% above its level a decade earlier. The Centers for Disease Control and Prevention (CDC) still describes these figures as provisional, and says some places may show increases the national data miss.

Women's share of the syphilis story

England's overall fall hides a rise among women. Infectious syphilis diagnoses dropped 13.5% in 2025 overall. Among women who have sex with men, they rose 4.8%, from 838 to 878. The numbers are small, and gay, bisexual and other men who have sex with men accounted for 5,164 diagnoses.

Australia shows a longer trend. Syphilis diagnoses among women quadrupled over the decade to 2024, the Kirby Institute reported. Men still made up 80% of cases. In Europe, the ECDC says syphilis is rising among heterosexual people, particularly women of reproductive age.

US data offer a counterpoint for the most recent year. Primary and secondary syphilis among women fell 13.8% in 2024, to 11,859 provisional cases. Congenital syphilis still rose 1.6% to 3,941 cases, the 12th annual increase.

Why pregnancy care is the pressure point

Europe's congenital syphilis cases rose from 78 in 2023 to 140 in 2024, across 14 reporting countries. "Most distressingly, between 2023 and 2024, we have seen a near doubling of congenital syphilis," said Bruno Ciancio, a unit head at the ECDC.

WHO estimates syphilis in pregnancy led to 390,000 adverse birth outcomes worldwide in 2022. More than half, 53%, occurred in women who attended antenatal care but weren't screened. A further 21% occurred in women who didn't attend care at all.

England's congenital cases rose from one in 2015 to 13 in 2023, Pulse reported from UKHSA data. The UK National Screening Committee is consulting on a routine third-trimester test until 3 January 2027. Its modelling found universal repeat screening unlikely to be cost-effective under current assumptions.

Hungary has taken a different decision. It has required a second syphilis test around weeks 24 to 28 of pregnancy since 1 September, after congenital cases rose there.

What the data show about older adults

US adults aged 55 and over recorded steep rises from 2012 to 2022, NBC News reported from CDC data. Syphilis cases rose seven-fold, gonorrhoea nearly five-fold and chlamydia more than three-fold.

Among women aged 55 and over, the rise started from a low base. Primary and secondary syphilis cases rose from 41 in 2010 to 578 in 2022, Healio reported from CDC data. Gonorrhoea cases rose from 443 to 2,684.

UK figures reported by Euronews show 1,649 gonorrhoea, chlamydia and syphilis diagnoses among people aged 65 and over in 2023. The 2014 figure was 576. The article gives no split by sex.

England's surveillance data add context. A study in Perspectives in Public Health found people aged 45 and over made up 8% of new STI diagnoses in 2019. Men accounted for 73.7% of them. Gonorrhoea and chlamydia rose in this group from 2014 to 2019, while the rise in all new STIs wasn't statistically significant. Diagnosis counts alone can't show how much of any increase reflects more testing.

What women can do

Syphilis sores can be painless or hidden and often heal without treatment, UKHSA says. Its guidance advises regular testing for anyone sexually active, especially before sex with a new partner. It also advises testing after symptoms or a partner's diagnosis.

Age doesn't remove the risk. The American Sexual Health Association says lower oestrogen after menopause can make tiny tears during sex more likely, which may raise infection risk. It also warns that women may put dryness, irritation or urinary symptoms down to ageing and delay testing. New symptoms need assessment by a health professional.

WHO says condoms should be used where possible, while noting they don't protect against sores outside the genitals. In pregnancy, WHO recommends early syphilis screening and treatment for all women as part of antenatal care. Testing is free and confidential on the NHS in the UK, and services elsewhere vary by country.

Thirteen of the 29 countries reporting to the ECDC charge out-of-pocket costs for basic STI tests. WHO adds that molecular tests for chlamydia and gonorrhoea are largely unavailable in low- and middle-income countries. UKHSA's three-year plan for England aims to expand testing and eliminate congenital syphilis, and the screening consultation closes on 3 January 2027.

Anyone affected by the issues in this article can ask a sexual health service, midwife or doctor for support.

This content is for information only and does not replace advice from a qualified health professional.

Get the week's essential women's health journalism

Evidence-based reporting, delivered to your inbox every week. No hype, no fads.